Insider trades

Paul J. Mellett, Chief Officer of Enanta Pharmaceuticals ENTA, has filed 0 purchases and 6 sales on the open market. The latest trade was on 25/02/12.

Paul J. Mellett

Chief Fin. & Admin Officer
First filing
23/01/10
Trades
21 trades
Buys / sales
0 / 6
12-month net buying
No record
Last trade
25/02/12

Trading activity

Transactions

Trade type
Open-market sale10b5-1 plan24/12/0624/12/102,591 sh$8.06$20,883.46−2.7%
Open-market sale23/12/0523/12/062,412 sh$9.63$23,227.56−2.5%
ENTA
Open-market sale23/03/1523/03/1710,440 sh2 trades$44.43avg.$463,802.2−9.7%
ENTA
Open-market sale23/02/0923/02/135,000 sh2 trades$53.76avg.$268,816−5.7%